Tue Mar 17th, 2020 at 09:44:25 AM EST
In a moment of global crisis, the worst of human kind outs itself ... or society can come together to fight a common enemy. The ultra-narcist in the leader of America came to the forefront: Buy the German vaccine and we'll market as ::
FOR AMERICA ONLY!
"We've got the BEST doctors, scientists, hospitals ... we're doing a great job. Very early I closed to borders to China ... saved thousands of lives!"
More below the fold ...
Frontpaged - Frank Schnittger
MAKE AMERICA GREAT AGAIN!!
h/t Cat on March 2, 2020 ...
Perfect. CSSE has been hijacked "in real-time".
Meanwhile in the lands of greater fool.
Coronavirus funding talks held up over drug price language
The odious haggles over "fair and reasonable" price to re-purchase "large quantities of coronavirus diagnostics, treatments and vaccine when it becomes available" from
Johnson & Johnson, Regeneron Pharmaceuticals Inc., Pfizer Inc., Sanofi, GlaxoSmithKline PLC, Gilead Sciences Inc., Novavax Inc., Inovio Pharmaceuticals Inc., CureVac AG and Moderna Inc.
My recent post - MAGA: Trump Poaching German Virologists.
Of course once the theft "for America only" leaked out, the White House PR came forward with a denial after a denial: "We have the best science and virologists, we don't need foreign know-how."
Trump's MAGA Takes a Hit By Merkel
Vaccine 'for the whole world'
On Sunday, the head of CureVac's biggest investor said that an exclusive contract with the US was out of the question.
"We want to develop a vaccine for the whole world and not individual countries," the chief executive of dievini Hopp Bio Tech Holding, Christof Hettich, told the Mannheimer Morgen newspaper, echoing a similar statement in the company's press statement.
Curevac-Investor: "Wollen Impfstoff für die ganze Welt entwickeln"
○ President Trump Meeting with Pharmaceutical Executives on Coronavirus | C-Span video |
From my earlier post ...
CureVac CEO Daniel Menichella Discusses Coronavirus Vaccine Development with U.S. President Donald Trump and Members of Coronavirus Task Force
TÜBINGEN, Germany/ Boston - March 02, 2020 - Daniel Menichella, CEO of biopharmaceutical company CureVac, was today invited to the White House to discuss strategies and opportunities for the rapid development and production of a coronavirus vaccine with U.S. President Donald Trump, Vice President Mike Pence, members of the White House Coronavirus Task Force and high-ranking representatives of pharmaceutical and biotech companies working on the outbreak's response.
In the discussion, Menichella highlighted the potential of CureVac's mRNA platform for vaccine development based on mRNA technology. "We are very confident that we will be able to develop a potent vaccine candidate within a few months, said CureVac CEO Daniel Menichella. "We can rely on the data of a Phase 1 rabies study in which we were able to immunize all participants with a very low dose. On this basis, we are working intensively to achieve a very low dose for the CoV vaccine as well. In addition, CureVac has a GMP-certified production facility which enables us to produce up to ten million vaccine doses in one production run."
The president reportedly offered biopharmaceutical company CureVac "large sums of money" to develop its COVID-19 vaccine exclusively for the United States
On March 11, CureVac released a statement that CEO Daniel Menichella, a U.S. citizen, was unexpectedly leaving the firm and would be replaced by the company's founder, Ingmar Hoerr. At the start of the month, Menichella was invited to the White House in Washington, D.C., to discuss strategy for the rapid development and production of a coronavirus vaccine with Trump, Vice President Mike Pence and members of the White House coronavirus task force.
CureVac has been working on a COVID-19 vaccine since January. German billionaire Dietmar Hopp, a co-founder of software group SAP and major investor in German professional soccer team TSG Hoffenheim, is the company's main shareholder, followed by the Bill and Melinda Gates Foundation.
German Economics Minister Peter Altmaier on Sunday praised CureVac for rejecting the U.S. offers. "Germany is not for sale," said Altmaier. The German government noted as well that CureVac's research has been backed by state subsidies. "The German government has a strong interest in developing treatments and vaccines in Germany and Europe," Altmaier said.
Reports of the Trump offer came over the weekend, as Germany, along with much of Europe, introduced strict new measures to combat the spread of CONVID-19. The World Health Organization has said Europe is the new epicenter of the global pandemic.
Company Founder Ingmar Hoerr Succeeds Daniel Menichella, a US citizen, as CEO of CureVac AG
TÜBINGEN, Germany/ BOSTON - March 11, 2020 - CureVac AG, a clinical stage biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that company founder and Chairman of the Supervisory Board Ingmar Hoerr is replacing Daniel Menichella in his function as Chief Executive Officer (CEO).
"On behalf of the Supervisory Board I would like to thank Dan Menichella very much for the great contributions he has done for CureVac in recent years," said founder and incoming CEO Ingmar Hoerr. "He started as Chief Business Officer of CureVac AG and CEO of CureVac's US subsidiary, prior to his appointment as Chief Executive Officer in 2018. Dan has been developing our business and advancing important product candidates including our phase 1 rabies program CV 7202, our phase 1 immuno oncology therapy trial CV 8102 and the recent start of our Coronavirus vaccine program. He was also largely responsible for the cooperation agreements with Eli Lilly, CRISPR Therapeutics and the Danish biotech company Genmab." I want to thank Dan for his leadership having built a terrific global team.
Hoerr also said: "CureVac has a great team, extraordinary expertise and huge potential. Together, we will continue to focus fully on taking the company to the next stage of its development and advance our clinical product pipeline with the goal of bringing mRNA-based drugs to patients. The vaccine against Covid-19 plays a key role here.".
No surprise .... shine a light on the facts, can't hide from CoV-2 ... European countries and the US have shunned their responsibility to their citizens.
All I've heard from PM Mark Rutte was smooth-talking PR bullshit ... acclaiming the wisdom of his "experts" who in turn praised the "courage" of the politicians. 😎😎
○ Harvard: 7 myths about social distancing busted (USA Today)
Recent diary ...
○ Outbreak — Herd Immunity Is Damning!
More to follow ...